Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk
Abstract Background Previous work has shown a role of CCL2, a key chemokine governing monocyte trafficking, in atherosclerosis. However, it remains unknown whether targeting CCR2, the cognate receptor of CCL2, provides protection against human atherosclerotic cardiovascular disease. Methods Computat...
Saved in:
Similar Items
-
Sleep Quality and Cognitive Skills Impact Neurocognitive Function and Reduce Sports-Related Injury Risk
by: Brett Haskell, Ph.D., C.M.P.C., et al.
Published: (2025-04-01) -
Indications for Biceps Tenodesis in Injured Overhead Throwing Athletes Lack Consensus: A Systematic Review and Cross-Sectional Survey
by: Aaron D. Sciascia, Ph.D., A.T.C., P.E.S., S.M.T.C., F.A.S.S.E.T., et al.
Published: (2025-06-01) -
The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases
by: Marek J. Konieczny, et al.
Published: (2025-01-01) -
Outcome of a bilateral mastectomy in a Criollo mare with adenocarcinoma - case report
by: I.P.O. Santos, et al.
Published: (2025-02-01) -
Energy Efficient Homes: An Introduction to Carbon Footprints
by: Nicholas W. Taylor, et al.
Published: (2008-07-01)